Zogenix, Inc. (ZGNX): Price and Financial Metrics
Zogenix, Inc. (ZGNX)
Today's Latest Price: $25.08 USD
1.39 (5.87%)
Updated Feb 28 12:00am
Add ZGNX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ZGNX Stock Summary
- Of note is the ratio of Zogenix Inc's sales and general administrative expense to its total operating expenses; only 5.72% of US stocks have a lower such ratio.
- With a price/sales ratio of 1,421.15, Zogenix Inc has a higher such ratio than 99.72% of stocks in our set.
- In terms of twelve month growth in earnings before interest and taxes, Zogenix Inc is reporting a growth rate of 175.17%; that's higher than 93.07% of US stocks.
- Stocks that are quantitatively similar to ZGNX, based on their financial statements, market capitalization, and price volatility, are CRMD, WKHS, BPMX, NLNK, and SAGE.
- Visit ZGNX's SEC page to see the company's official filings. To visit the company's web site, go to www.zogenix.com.
ZGNX Daily Price Range
ZGNX 52-Week Price Range
ZGNX Stock Price Chart More Charts
ZGNX Price/Volume Stats
| Current price | $25.08 | 52-week high | $57.22 |
| Prev. close | $23.69 | 52-week low | $18.27 |
| Day low | $22.46 | Volume | 1,638,000 |
| Day high | $25.16 | Avg. volume | 1,205,792 |
| 50-day MA | $45.62 | Dividend yield | N/A |
| 200-day MA | $44.51 | Market Cap | 1.11B |
Zogenix, Inc. (ZGNX) Company Bio
Zogenix develops and commercializes therapies for the treatment of central nervous system disorders. The company was founded in 2006 and is based in San Diego, California.
Top Stories View All
How Low Will Stocks Go?
Best & Worst Performing Stock Industries for February 28, 2020
Best & Worst Performing Small Cap Stocks for February 28, 2020
Best & Worst Performing Mid Cap Stocks for February 28, 2020
Best & Worst Performing Large Cap Stocks for February 28, 2020
View All Top Stories
Loading social stream, please wait...